Proceeds from exercise of common stock warrants Proceeds from Warrant Exercises Supplemental disclosure of cash flow information: Supplemental Cash Flow Information [Abstract] Customer [Domain] Customer [Domain] Net Loss Per Share Earnings Per Share, Policy [Policy Text Block] Awards released (in shares) Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period Fair Value Hierarchy and NAV [Domain] Fair Value Hierarchy and NAV [Domain] Leasehold improvements Leasehold Improvements [Member] Net loss Net loss Net Income (Loss) Attributable to Parent Entity Emerging Growth Company Entity Emerging Growth Company Shares outstanding (in shares) Preferred Stock, Shares Outstanding Innovatus Life Sciences Lending Fund Innovatus Life Sciences Lending Fund [Member] Innovatus Life Sciences Lending Fund Income Statement Location [Axis] Income Statement Location [Axis] Statistical Measurement [Domain] Statistical Measurement [Domain] Entity Address, Address Line One Entity Address, Address Line One Rental Property, by Type [Axis] Rental Property, by Type [Axis] Rental Property, by Type Depreciation and amortization Cost, Depreciation and Amortization Schedule of Future Minimum Aggregate Payments for Outstanding Borrowings Schedule of Maturities of Long-term Debt [Table Text Block] Segment Reporting Segment Reporting, Policy [Policy Text Block] Awards canceled, Weighted-Average Grant Date Fair Value (in dollars per share) Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value Entity Filer Category Entity Filer Category Forfeited (in shares) Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period Other assets Other Assets, Noncurrent Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table] Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table] Covid-19 Coronavirus, Aid, Relief, And Economic Securities (CARES) Act Disclosure [Text Block] Coronavirus, Aid, Relief, And Economic Securities (CARES) Act Disclosure Shares that remain available for future awards (in shares) Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Available for Grant Dividend yield Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate Net change in cash, cash equivalents and restricted cash Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect Expected volatility Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate Blue Shield Blue Shield [Member] Blue Shield Common stock Common Stock, Number of Shares, Par Value and Other Disclosures [Abstract] 2023 Long-Term Debt, Maturity, Year Two Stock-based compensation APIC, Share-based Payment Arrangement, Increase for Cost Recognition 2021 (remaining) Long-Term Debt, Maturity, Remainder of Fiscal Year Document Fiscal Year Focus Document Fiscal Year Focus Repayment of Paycheck Protection Program loan Repayments of Bank Debt Royalty obligation, percent of net sales Royalty Obligation, Percentage of Sales Royalty Obligation, Percentage of Sales Organization, Consolidation and Presentation of Financial Statements [Abstract] Anti-dilutive securities excluded from computation (in shares) Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount Research and development Research and Development Expense [Member] Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Aggregate Intrinsic Value [Abstract] Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Aggregate Intrinsic Value [Abstract] Coronavirus, Aid, Relief, And Economic Securities (CARES) Act, deferred tax assets, valuation allowance Coronavirus, Aid, Relief, And Economic Securities (CARES) Act, Deferred Tax Assets, Valuation Allowance Coronavirus, Aid, Relief, And Economic Securities (CARES) Act, Deferred Tax Assets, Valuation Allowance Sale of Stock [Axis] Sale of Stock [Axis] Awards granted, Weighted-Average Grant Date Fair Value (in dollars per share) Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value Janssen Promotion Agreement Janssen Promotion Agreement [Member] Janssen Promotion Agreement Outstanding, Aggregate Intrinsic Value Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Aggregate Intrinsic Value, Outstanding Award Type [Domain] Award Type [Domain] Common stock options Equity Option [Member] Assets Assets [Abstract] Stock Options, Additional Disclosures [Abstract] Share-based Compensation Arrangement by Share-based Payment Award, Options, Additional Disclosures [Abstract] 2024 Long-Term Debt, Maturity, Year Three Operating lease, renewal term Operating Leases, Renewal Term Operating Leases, Renewal Term Vested and expected to vest, June 30, 2021, Weighted Average Exercise Price (in dollars per share) Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price Accrued purchases of goods and services Accrued Purchase, Goods and Services, Current Accrued Purchase, Goods and Services, Current Awards granted (in shares) Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period New Accounting Pronouncement, Early Adoption [Line Items] New Accounting Pronouncements or Change in Accounting Principle [Line Items] Percent of total revenue Concentration Risk, Percentage Preferred stock, $0.001 par value; 10,000,000 shares authorized, no shares issued or outstanding at June 30, 2021 and December 31, 2020 Preferred Stock, Value, Issued New Accounting Pronouncement, Early Adoption [Table] Accounting Standards Update and Change in Accounting Principle [Table] Outstanding, December 31, 2020 (in shares) Outstanding, June 30, 2021 (in shares) Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number Entity Address, City or Town Entity Address, City or Town Accumulated Deficit Retained Earnings [Member] IPO IPO [Member] Debt Instrument [Axis] Debt Instrument [Axis] Rental Property, by Type [Domain] Rental Property, by Type [Domain] Rental Property, by Type Advertising and Marketing Costs Advertising Cost [Policy Text Block] Commitments and Contingencies Commitments and Contingencies Disclosure [Text Block] Term loan, paid in-kind loans issued Debt Instrument, Paid In Kind Loans Issued Debt Instrument, Paid In Kind Loans Issued Warrant expiration September 7, 2024 Expiration Sep 7, 2024 [Member] Expiration Sep 7, 2024 Retirement of common stock in exchange for common stock warrant Stock Repurchased and Retired During Period, Value Joint venture, quarterly promotion fee Joint Venture, Quarterly Promotion Fee Joint Venture, Quarterly Promotion Fee Accounts receivable, net Increase (Decrease) in Accounts Receivable Costs incurred, but not paid, in connection with capital expenditures Capital Expenditures Incurred but Not yet Paid Maximum employee payroll deduction percentage Share-based Compensation Arrangement by Share-based Payment Award, Maximum Employee Subscription Rate Office Office [Member] Office Property, Plant and Equipment [Line Items] Property, Plant and Equipment [Line Items] Commitments and Contingencies Disclosure [Abstract] Supplier [Axis] Supplier [Axis] Warrant expiration March 31, 2026 Expiration Mar 31, 2026 [Member] Expiration Mar 31, 2026 Initial license fee License Agreement, Initial License Fee License Agreement, Initial License Fee Entity Interactive Data Current Entity Interactive Data Current Number of operating segments Number of Operating Segments Net loss per share, basic (in dollars per share) Earnings Per Share, Basic Outstanding, December 31, 2020 (in shares) Outstanding, June  30, 2021 (in shares) Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number Document Type Document Type 2022 Long-Term Debt, Maturity, Year One Disaggregation of Revenue Disaggregation of Revenue [Table Text Block] Medicare Medicare [Member] Medicare Shipping and Handling Shipping and Handling [Member] Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward] Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward] Entity Current Reporting Status Entity Current Reporting Status Joint venture quarterly promotion fee cap Joint Venture, Quarterly Promotion Fee, Capped Amount, Percentage Above Baseline Joint Venture, Quarterly Promotion Fee, Capped Amount, Percentage Above Baseline Paid in-kind note Payment in Kind (PIK) Note [Member] Research and Development Research and Development Expense, Policy [Policy Text Block] Warrant expiration December 7, 2025 Expiration Dec 7, 2025 [Member] Expiration Dec 7, 2025 Prepaid expenses and other current assets Increase (Decrease) in Prepaid Expense and Current Other Assets Increase (Decrease) in Prepaid Expense and Current Other Assets Accounts Receivable Receivable Benchmark [Member] Receivable Benchmark Plan Name [Axis] Plan Name [Axis] Assets: Assets, Fair Value Disclosure [Abstract] Total borrowings, net of discounts and debt issuance costs Long-term Debt Level 1 Fair Value, Inputs, Level 1 [Member] Document Transition Report Document Transition Report United Healthcare United Healthcare [Member] United Healthcare Total liabilities and stockholders' equity Liabilities and Equity Other accrued liabilities Other Accrued Liabilities, Current Equipment purchased under capital lease obligations Equipment Purchased Under Capital Lease Equipment Purchased Under Capital Lease Exercised, Weighted Average Exercise Price (in dollars per share) Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price Restricted cash Restricted Cash Additional paid-in capital Additional Paid in Capital Supplemental disclosure of non-cash items: Supplemental Cash Flow Elements [Abstract] Liabilities and Stockholders' Equity Liabilities and Equity [Abstract] Accounts payable Increase (Decrease) in Accounts Payable Termination of agreement Joint Venture, Termination, Consideration Receivable Joint Venture, Termination, Consideration Receivable Cash flows from operating activities: Net Cash Provided by (Used in) Operating Activities, Continuing Operations [Abstract] Non-cash interest expense Paid-in-Kind Interest Exercise of stock options Stock Issued During Period, Value, Stock Options Exercised Minimum Minimum [Member] Future minimum royalty commitment Royalty Guarantees, Commitments, Amount Balance Sheet Location [Domain] Balance Sheet Location [Domain] Prometheus Laboratories Prometheus Laboratories, Inc. [Member] Prometheus Laboratories, Inc. Selling, general and administrative expenses Selling, General and Administrative Expense Shares authorized (in shares) Preferred Stock, Shares Authorized Class of Warrant or Right [Domain] Class of Warrant or Right [Domain] 2019 Incentive Award Plan Incentive Award Plan, 2019 [Member] Incentive Award Plan, 2019 Trading Symbol Trading Symbol Interest Long-term Debt, Undiscounted Interest Amount Long-term Debt, Undiscounted Interest Amount Current liabilities: Liabilities, Current [Abstract] Issuance of stock in public offering, net of issuance costs of $4,435 Stock Issued During Period, Value, New Issues Revenue Recognition Revenue [Policy Text Block] Borrowings Debt Disclosure [Text Block] Stock Option Plan Share-based Payment Arrangement [Text Block] Prepaid product royalties Prepaid Royalties Level 3 Fair Value, Inputs, Level 3 [Member] Fair Value Measurement Inputs and Valuation Techniques [Line Items] Fair Value Measurement Inputs and Valuation Techniques [Line Items] Accounting Policies [Abstract] Outstanding, Weighted Average Remaining Contractual Term Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term Payment of issuance costs related to public offering Payments of Stock Issuance Costs Issuance of stock in public offering, net of issuance costs of $4,435 (in shares) Stock Issued During Period, Shares, New Issues Term loan, paid in-kind, interest rate Debt Instrument, Stated Interest Rate, Paid In-Kind Debt Instrument, Stated Interest Rate, Paid In-Kind Common stock, $0.001 par value; 200,000,000 shares authorized at June 30, 2021 and December 31, 2020; 16,126,784 and 12,652,308 shares issued and outstanding at June 30, 2021 and December 31, 2020, respectively Common Stock, Value, Issued Disaggregation of Revenue [Line Items] Disaggregation of Revenue [Line Items] Stock options, cost not yet recognized, remaining weighted average vesting period Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition Outstanding, December 31, 2020 (in dollars per share) Outstanding, June 30, 2021 (in dollars per share) Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value Customer Concentration Risk Customer Concentration Risk [Member] Commitments and contingencies (Note 5) Commitments and Contingencies Paycheck Protection Program, CARES Act Paycheck Protection Program, CARES Act [Member] Paycheck Protection Program, CARES Act Schedule of Fair Value Assumptions, Stock Options Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions [Table Text Block] Product Concentration Risk Product Concentration Risk [Member] Prepaid maintenance and insurance contracts Prepaid Maintenance and Insurance Contracts Prepaid Maintenance and Insurance Contracts Antidilutive Securities, Name [Domain] Antidilutive Securities, Name [Domain] Document Period End Date Document Period End Date Total operating expenses Costs and Expenses Entity Registrant Name Entity Registrant Name Cash, Cash Equivalents and Restricted Cash Cash and Cash Equivalents, Policy [Policy Text Block] Collaborative Arrangement and Arrangement Other than Collaborative [Axis] Collaborative Arrangement and Arrangement Other than Collaborative [Axis] Warrants issued to purchase redeemable convertible preferred stock (in shares) Class of Warrant or Right, Outstanding Proceeds from public offering, net Sale of Stock, Consideration Received on Transaction Prepaid and other current assets Prepaid Expense and Other Assets, Current Collaboration agreement, collaboration expenses Collaboration Agreement, Collaboration Expenses Collaboration Agreement, Collaboration Expenses Financial Instrument [Axis] Financial Instrument [Axis] Selling, general and administrative Selling, General and Administrative Expenses [Member] Accrued and other current liabilities Accrued and other current liabilities Accrued Liabilities, Current Revenue Revenue from Contract with Customer, Excluding Assessed Tax Healthcare insurers Healthcare Insurers [Member] Healthcare Insurers Stock options Share-based Payment Arrangement, Option [Member] Office and Laboratory Office and Laboratory [Member] Office and Laboratory Equity [Abstract] Fair Value Hierarchy and NAV [Axis] Fair Value Hierarchy and NAV [Axis] Comprehensive Loss Comprehensive Income, Policy [Policy Text Block] Reorganizations [Abstract] Common Stock Common Stock [Member] Loss from operations Operating Income (Loss) Property, Plant and Equipment [Table] Property, Plant and Equipment [Table] Organization Organization, Consolidation, Basis of Presentation, Business Description and Accounting Policies [Text Block] Increase (Decrease) in Stockholders' Equity [Roll Forward] Increase (Decrease) in Stockholders' Equity [Roll Forward] Stock-based compensation Share-based Payment Arrangement, Noncash Expense Additional Paid-In Capital Additional Paid-in Capital [Member] Cash and cash equivalents Cash and cash equivalents Cash and Cash Equivalents, at Carrying Value Net exercise of common stock warrants (in shares) Stock Issued During Period, Shares, Warrants Exercised, Net Stock Issued During Period, Shares, Warrants Exercised, Net Long-term Debt, Type [Domain] Long-term Debt, Type [Domain] Proceeds from Paycheck Protection Program loan Proceeds from Bank Debt Collaborative Arrangement and Arrangement Other than Collaborative [Domain] Collaborative Arrangement and Arrangement Other than Collaborative [Domain] Schedule of Restricted Stock Unit Activity Share-based Payment Arrangement, Restricted Stock Unit, Activity [Table Text Block] Number of common shares to be called upon exercise of warrants (in shares) Class of Warrant or Right, Number of Securities Called by Warrants or Rights Other assets Other Assets [Member] Other (expense) income, net Other Nonoperating Income (Expense) Computer equipment and software Computer Equipment and Software [Member] Computer Equipment and Software Joint venture, quarterly promotion fee per prescription Joint Venture, Quarterly Promotion Fee Per Prescription Joint Venture, Quarterly Promotion Fee Per Prescription Retirement of common stock in exchange for common stock warrant (in shares) Stock Repurchased and Retired During Period, Shares Purchases of property and equipment Payments to Acquire Property, Plant, and Equipment Maximum Maximum [Member] Share-based Payment Arrangement [Abstract] Total liabilities Liabilities Accrued and other current liabilities Schedule of Accrued Liabilities [Table Text Block] Award Type [Axis] Award Type [Axis] Granted, Weighted Average Exercise Price (in dollars per share) Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price Options exercised, June 30, 2021, Weighted Average Exercise Price (in dollars per share) Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Weighted Average Exercise Price Outstanding, Aggregate Intrinsic Value Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value Expired (in shares) Share-based Compensation Arrangement by Share-based Payment Award, Options, Expirations in Period Total stockholders' equity Beginning balance Ending balance Stockholders' Equity Attributable to Parent Shares issued (in shares) Common Stock, Shares, Issued Shares issued (in shares) Preferred Stock, Shares Issued Preferred stock Preferred Stock, Number of Shares, Par Value and Other Disclosures [Abstract] Allegheny Health Network Research Institute Allegheny Health Network Research Institute [Member] Allegheny Health Network Research Institute Research and Development Arrangement, Contract to Perform for Others, Type [Axis] Research and Development Arrangement, Contract to Perform for Others, Type [Axis] Stockholders' equity: Stockholders' Equity Attributable to Parent [Abstract] Concentration of Credit Risk and Other Risk and Uncertainties Concentration Risk, Credit Risk, Policy [Policy Text Block] Balance Sheet Location [Axis] Balance Sheet Location [Axis] Risk-free interest rate, minimum Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Minimum Measurement Frequency [Domain] Measurement Frequency [Domain] 2017 Term loan Term 2017 [Member] Term 2017 Interest expense Interest Expense Term loan, effective interest rate Debt Instrument, Interest Rate, Effective Percentage Expected volatility rate, maximum Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Maximum City Area Code City Area Code Accumulated deficit Accumulated deficit Retained Earnings (Accumulated Deficit) Stock options, expiration period Share-based Compensation Arrangement by Share-based Payment Award, Expiration Period Fair Value Measurement Inputs and Valuation Techniques [Table] Fair Value Measurement Inputs and Valuation Techniques [Table] Restricted stock units Restricted Stock Units (RSUs) [Member] Statement of Stockholders' Equity [Abstract] Statement of Stockholders' Equity [Abstract] Issuance of stock under Employee Stock Purchase Plan (in shares) Stock Issued During Period, Shares, Employee Stock Purchase Plans Assets under capital lease Assets Under Capital Lease [Member] Assets Under Capital Lease Risk-free interest rate Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate Schedule of Restricted Cash and Cash Equivalents Restrictions on Cash and Cash Equivalents [Table Text Block] Income Statement [Abstract] Income Statement [Abstract] Amendment Flag Amendment Flag Prepaid expenses and other current assets Prepaid Expense and Other Assets Proceeds from exercise of stock options Proceeds from Stock Options Exercised Forfeited, Weighted Average Exercise Price (in dollars per share) Share-based Compensation Arrangements by Share-based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price Income tax benefit Income Tax Expense (Benefit) Accounts receivable, net Accounts Receivable, after Allowance for Credit Loss, Current Term loan borrowings Proceeds from Issuance of Long-term Debt Equity Components [Axis] Equity Components [Axis] Fair Value Disclosures [Abstract] Antidilutive Securities [Axis] Antidilutive Securities [Axis] Total current assets Assets, Current Sale of Stock [Domain] Sale of Stock [Domain] Concentration Risk Type [Domain] Concentration Risk Type [Domain] Disaggregation of Revenue [Table] Disaggregation of Revenue [Table] Awards canceled (in shares) Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeited in Period Purchase obligation, to be paid remainder of fiscal year Purchase Obligation, to be Paid, Remainder of Fiscal Year Schedule of Stock by Class [Table] Schedule of Stock by Class [Table] Entity File Number Entity File Number Issuance of common stock warrant in exchange for retirement of common stock Adjustments to Additional Paid in Capital, Warrant Issued Statement of Financial Position [Abstract] Statement of Financial Position [Abstract] Expired, Weighted Average Exercise Price (in dollars per share) Share-based Compensation Arrangements by Share-based Payment Award, Options, Expirations in Period, Weighted Average Exercise Price Fair Value Measurements Fair Value Measurement, Policy [Policy Text Block] Product and Service [Axis] Product and Service [Axis] Schedule of Outstanding Warrants Schedule of Stockholders' Equity Note, Warrants or Rights [Table Text Block] Property, Plant and Equipment, Type [Domain] Long-Lived Tangible Asset [Domain] Cash flows from financing activities: Net Cash Provided by (Used in) Financing Activities, Continuing Operations [Abstract] Entity Incorporation, State or Country Code Entity Incorporation, State or Country Code Schedule of Cash and Cash Equivalents Schedule of Cash and Cash Equivalents [Table Text Block] Entity Small Business Entity Small Business Par value (in dollars per share) Preferred Stock, Par or Stated Value Per Share AHN Collaboration AHN Collaboration [Member] AHN Collaboration Revenue Benchmark Revenue Benchmark [Member] Equity Component [Domain] Equity Component [Domain] Research and Development Arrangement, Contract to Perform for Others, Type [Domain] Research and Development Arrangement, Contract to Perform for Others, Type [Domain] Entity Ex Transition Period Entity Ex Transition Period Accrued and other current liabilities Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities Capital lease obligations, current portion Capital Lease Obligations, Current Statement [Line Items] Statement [Line Items] Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Abstract] Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Abstract] Capital Royalty Partners II LP Capital Royalty Partners II LP [Member] Capital Royalty Partners II LP Term loan covenant, minimum unrestricted cash balance Debt Instrument, Covenant Compliance, Minimum Unrestricted Cash Balance Debt Instrument, Covenant Compliance, Minimum Unrestricted Cash Balance Counterparty Name [Domain] Counterparty Name [Domain] Debt Disclosure [Abstract] Entity Address, State or Province Entity Address, State or Province Level 2 Fair Value, Inputs, Level 2 [Member] Property, Plant and Equipment, Type [Axis] Long-Lived Tangible Asset [Axis] Two Major Suppliers Two Major Suppliers [Member] Two Major Suppliers Customer [Axis] Customer [Axis] Restructuring Cost and Reserve [Line Items] Restructuring Cost and Reserve [Line Items] Government Government1 [Member] Government1 Granted (in shares) Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross Entity Shell Company Entity Shell Company Local Phone Number Local Phone Number Schedule of Non-cash Stock-based Compensation Expense Share-based Payment Arrangement, Expensed and Capitalized, Amount [Table Text Block] Proceeds from the issuance of common stock in public offering, gross Proceeds from Issuance of Common Stock Total assets Assets Plan Name [Domain] Plan Name [Domain] Shares authorized (in shares) Common Stock, Shares Authorized Options exercisable, Weighted Average Remaining Contractual Term Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Weighted Average Remaining Contractual Term Cash paid for interest expense Interest Paid, Excluding Capitalized Interest, Operating Activities Product and Service [Domain] Product and Service [Domain] Research and development expenses Research and Development Expense Term loan, interest rate Debt Instrument, Interest Rate, Stated Percentage Other Financial Information Prepaid Expenses and Other Current Assets; Property, Plant and Equipment; and Accrued Liabilities [Text Block] Prepaid Expenses and Other Current Assets; Property, Plant and Equipment; and Accrued Liabilities Share-based Compensation Arrangement by Share-based Payment Award [Line Items] Share-based Compensation Arrangement by Share-based Payment Award [Line Items] Summary of Significant Accounting Policies Significant Accounting Policies [Text Block] Measurement Frequency [Axis] Measurement Frequency [Axis] Net cash used in operating activities Net Cash Provided by (Used in) Operating Activities Furniture and fixtures Furniture and Fixtures [Member] Schedule of Long-term Debt Instruments [Table] Schedule of Long-term Debt Instruments [Table] Entity Tax Identification Number Entity Tax Identification Number Term loan, fee incurred upon payment of final installment Debt Instrument, Fee Amount Weighted-average number of shares used to compute net loss per share, basic (in shares) Weighted Average Number of Shares Outstanding, Basic Net loss per share, diluted (in dollars per share) Earnings Per Share, Diluted Amortization of debt discount and debt issuance costs Amortization of Debt Issuance Costs and Discounts Shares issued in public offering, price per share (in dollars per share) Sale of Stock, Price Per Share Medicare Advantage Medicare Advantage [Member] Medicare Advantage Supplier [Domain] Supplier [Domain] Schedule of Restructuring and Related Costs [Table] Schedule of Restructuring and Related Costs [Table] Cost of revenue Cost of Revenue Term loan, prepayment premium percentage Debt Instrument, Prepayment Premium Percentage Debt Instrument, Prepayment Premium Percentage Net cash provided by (used in) financing activities Net Cash Provided by (Used in) Financing Activities Deferred tax liabilities Deferred Income Tax Liabilities, Net Stock options, vesting period Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period Loan payable Loans Payable [Member] Proceeds from government assistance Proceeds from Government Assistance Proceeds from Government Assistance Fair Value Measurements Fair Value Disclosures [Text Block] Loss before income taxes Income (Loss) Attributable to Parent, before Tax Accounts payable Accounts Payable, Current Remaining milestone obligation Milestone Obligation Milestone Obligation Concentration Risk Type [Axis] Concentration Risk Type [Axis] Depreciation and amortization Depreciation, Depletion and Amortization Advance royalties payment Advance Payment Advance Payment Accrued payroll and related expenses Accrued Salaries, Current Schedule of Fair Value, Financial Instrument Measured on a Recurring Basis Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Table Text Block] Accrued royalties Accrued Royalties, Current Shares outstanding (in shares) Beginning balance (in shares) Ending balance (in shares) Common Stock, Shares, Outstanding Financial Instruments [Domain] Financial Instruments [Domain] Supplier Concentration Risk Supplier Concentration Risk [Member] Sale of stock, percentage of ownership after transaction Sale of Stock, Percentage of Ownership after Transaction Costs of revenue Cost of Goods and Services Sold Janssen (SIMPONI) Janssen (SIMPONI) [Member] Janssen (SIMPONI) Concentration Risk Benchmark [Domain] Concentration Risk Benchmark [Domain] Line of Credit Facility, Lender [Domain] Line of Credit Facility, Lender [Domain] Stock-Based Compensation Employee Stock Ownership Plan (ESOP), Policy [Policy Text Block] AVISE CTD Test AVISE CTD Test [Member] AVISE CTD Test Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding [Roll Forward] Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding [Roll Forward] Cash flows from investing activities: Net Cash Provided by (Used in) Investing Activities, Continuing Operations [Abstract] Property and equipment Property, Plant and Equipment [Table Text Block] Laboratory equipment Laboratory Equipment [Member] Laboratory Equipment Income Statement Location [Domain] Income Statement Location [Domain] Debt instrument, term Debt Instrument, Term Warrant expiration January 19, 2026 Expiration Jan 19, 2026 [Member] Expiration Jan 19, 2026 Number of warrants exercised (in shares) Class of Warrant or Right, Number Of Warrants Exercised Class of Warrant or Right, Number Of Warrants Exercised Loss Contingencies [Line Items] Loss Contingencies [Line Items] Property and equipment, net Property and equipment, net Property, Plant and Equipment, Net Other prepaid and other current assets Other Prepaid Expense, Current Other non-current liabilities Other Liabilities, Noncurrent Lender Name [Axis] Lender Name [Axis] Loan repayment Repayments of Long-term Debt Debt Instrument [Line Items] Debt Instrument [Line Items] Total property and equipment Property and equipment, gross Property, Plant and Equipment, Gross Term loan, annual reduction in prepayment penalty percentage Debt Instrument, Prepayment Premium Percentage, Annual Reduction Debt Instrument, Prepayment Premium Percentage, Annual Reduction Number of shares exchanged for warrants (in shares) Exchange Agreement, Number Of Shares Exchanged For Warrants Exchange Agreement, Number Of Shares Exchanged For Warrants Accrued clinical study activity Accrued Liabilities, Clinical Study, Current Accrued Liabilities, Clinical Study, Current Document Quarterly Report Document Quarterly Report Class of warrant or right, exercise price of warrants or rights (in dollars per share) Class of Warrant or Right, Exercise Price of Warrants or Rights Vested and expected to vest, June 30, 2021 (in shares) Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number Term loan covenant, increase to interest rate Debt Instrument, Covenant Non-Compliance, Interest Rate, Increase (Decrease) Debt Instrument, Covenant Non-Compliance, Interest Rate, Increase (Decrease) Outstanding, December 31, 2020, Weighted Average Exercise Price (in dollars per share) Outstanding, June 30, 2021, Weighted Average Exercise Price (in dollars per share) Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price Warrants to purchase common stock Warrant [Member] Entity Common Stock, Shares Outstanding (in shares) Entity Common Stock, Shares Outstanding Operating expenses: Costs and Expenses [Abstract] Borrowings-non-current portion, net of discounts and debt issuance costs Long-term Debt, Excluding Current Maturities No expiration No expiration [Member] No expiration Exchanging Stockholders Exchanging Stockholders [Member] Exchanging Stockholders Stock-based compensation expense Share-based Payment Arrangement, Expense Client Client [Member] Client Shipping and Handling Costs Cost of Goods and Service [Policy Text Block] Coronavirus, Aid, Relief, And Economic Securities (CARES) Act, deferred tax assets, income tax benefit Coronavirus, Aid, Relief, And Economic Securities (CARES) Act, Deferred Tax Assets, Income Tax Benefit Coronavirus, Aid, Relief, And Economic Securities (CARES) Act, Deferred Tax Assets, Income Tax Benefit Expected volatility rate, minimum Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Minimum Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract] Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract] Document Fiscal Period Focus Document Fiscal Period Focus Counterparty Name [Axis] Counterparty Name [Axis] Options exercisable, Aggregate Intrinsic Value Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Aggregate Intrinsic Value Annual increase in purchase commitments Purchase Obligation, Annual Increase In Commitment, Percentage Purchase Obligation, Annual Increase In Commitment, Percentage Class of Warrant or Right [Axis] Class of Warrant or Right [Axis] Construction in progress Construction in Progress [Member] Cash, cash equivalents and restricted cash, beginning of period Cash, cash equivalents and restricted cash, end of period Total Cash, Cash Equivalents and Restricted Cash Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents Sale of stock, number shares issued (in shares) Sale of Stock, Number of Shares Issued in Transaction Par value (in dollars per share) Common Stock, Par or Stated Value Per Share Deferred offering costs reclassified to equity Deferred Offering Costs Reclassified to Equity Deferred Offering Costs Reclassified to Equity Risk-free interest rate, maximum Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Maximum Total Long-term Debt, Including Undiscounted Interest Long-term Debt, Including Undiscounted Interest Schedule of Concentration of Risk, by Risk Factor and Significant Payer Schedules of Concentration of Risk, by Risk Factor [Table Text Block] Current assets: Assets, Current [Abstract] Entity Central Index Key Entity Central Index Key Security Exchange Name Security Exchange Name Collaboration fee Collaboration Agreement, Annual Collaboration Fee Collaboration Agreement, Annual Collaboration Fee Other Financial Information [Abstract] Other Financial Information Money market funds, included in cash and cash equivalents Cash and Cash Equivalents, Fair Value Disclosure Principal payment on capital lease obligations Repayments of Long-term Capital Lease Obligations Exercise of stock options (in shares) Exercised (in shares) Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period Purchase obligation, due in year one Purchase Obligation, to be Paid, Year One Weighted-average number of shares used to compute net loss per share, diluted (in shares) Weighted Average Number of Shares Outstanding, Diluted Recurring Fair Value, Recurring [Member] Accrued interest Interest Payable, Current Long-term Debt, Type [Axis] Long-term Debt, Type [Axis] Current Fiscal Year End Date Current Fiscal Year End Date Schedule of Stock Option Activity Share-based Payment Arrangement, Option, Activity [Table Text Block] Licensing Agreements License Agreement Terms [Member] Stockholders' Equity Stockholders' Equity Note Disclosure [Text Block] Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table Text Block] Statement of Cash Flows [Abstract] Statement of Cash Flows [Abstract] Options exercisable, June 30, 2021 (in Shares) Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Number Class of Stock [Line Items] Class of Stock [Line Items] Net cash used in investing activities Net Cash Provided by (Used in) Investing Activities Changes in assets and liabilities: Increase (Decrease) in Operating Capital [Abstract] Less: accumulated depreciation and amortization Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment Issuance of stock under Employee Stock Purchase Plan Stock Issued During Period, Value, Employee Stock Purchase Plan Prepaid expenses table Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Table Text Block] Awards released, Weighted-Average Grant Date Fair Value (in dollars per share) Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value Other Other Customer [Member] Expected term (in years) Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Term Total current liabilities Liabilities, Current Employee stock purchase plan Employee Stock [Member] Money market funds, included in cash and cash equivalents Money Market Funds [Member] Loss Contingencies [Table] Loss Contingencies [Table] Vested and expected to vest, Aggregate Intrinsic Value Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Aggregate Intrinsic Value Entity Address, Postal Zip Code Entity Address, Postal Zip Code Unamortized debt discount and issuance costs Debt Instrument, Unamortized Discount (Premium) and Debt Issuance Costs, Net Warrant expiration April 1, 2026 Expiration Apr 1, 2026 [Member] Expiration Apr 1, 2026 Debt Instrument, Name [Domain] Debt Instrument, Name [Domain] Title of 12(b) Security Title of 12(b) Security Diagnostic testing supplies Other Assets, Current Proceeds from common stock issued under Employee Stock Purchase Plan Proceeds from Stock Plans Statement [Table] Statement [Table] Advertising expense Advertising Expense Recent Accounting Pronouncements Not Yet Adopted, Recently Adopted Accounting Standards New Accounting Pronouncements, Policy [Policy Text Block] Other assets Increase (Decrease) in Other Noncurrent Assets Stock options, unrecognized compensation cost Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount Stock issuance costs Estimated offering expenses for aggregate expenses Stock Issuance Costs Stock Issuance Costs Statistical Measurement [Axis] Statistical Measurement [Axis] Cover [Abstract] Goodwill Goodwill Remaining milestone obligation, fair value Milestone Contingency, Fair Value Disclosure Milestone Contingency, Fair Value Disclosure Net exercise of common stock warrants Stock Issued During Period, Value, Warrants Exercised, Net Stock Issued During Period, Value, Warrants Exercised, Net Cost of revenue Cost of Sales [Member] Adjustments to reconcile net loss to net cash used in operating activities: Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract] Concentration Risk Benchmark [Axis] Concentration Risk Benchmark [Axis] Operating lease, rent expense Operating Leases, Rent Expense Schedule of Fair Value Assumptions, Employee Stock Purchase Plan Schedule of Share-based Payment Award, Employee Stock Purchase Plan, Valuation Assumptions [Table Text Block] Deferred income taxes Deferred Income Tax Expense (Benefit) Vested and expected to vest, Weighted Average Remaining Contractual Term Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Remaining Contractual Term